| Trial ID: | L1452 |
| Source ID: | NCT00175149
|
| Associated Drug: |
Alfacalcidiol
|
| Title: |
Active Vitamin D Effect on Left Ventricular Hypertrophy
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Secondary Hyperparathyroidism|Left Ventricular Hypertrophy
|
| Interventions: |
DRUG: Alfacalcidiol
|
| Outcome Measures: |
Primary: The effect of dihydroxycholecalciferol on left ventricular hypertrophy, 6 month | Secondary: Changes in the activity of the renin-angiotensin system, 6 month|Changes in left ventricular function, 6 month
|
| Sponsor/Collaborators: |
Sponsor: Per Ivarsen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-01
|
| Completion Date: |
2008-12
|
| Results First Posted: |
|
| Last Update Posted: |
2015-12-08
|
| Locations: |
Department of Renal Medicne C, Skejby Hospital, Aarhus, 8200, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00175149
|
